Ery-Ped
- Product NDC
- 80005-155
- 11-digit product format
- 800050155
- Labeler code
- 80005
- Product ID
- 80005-155_d05c0828-9fce-4a60-a2ac-d9a1fbf17792
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin Ethylsuccinate
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Carnegie Pharmaceuticals LLC
- Application
- NDA050207
- Marketing category
- NDA
- Marketing start
- 2025-01-15
- Substance
- ERYTHROMYCIN ETHYLSUCCINATE
- Active strength
- 400 mg/5mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ery-Ped
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 400 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1014KSJ86F |
| Rxcui | 686418, 686420 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80005-155-18 | Ery-Ped | 100 mL in 1 BOTTLE | SUSPENSION | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80005-155 | ERY-PED (ERYTHROMYCIN ETHYLSUCCINATE) SUSPENSION [CARNEGIE PHARMACEUTICALS LLC] | 1 | Current NDC, 1 package rows | 20250117_94b4658c-f4f5-4257-a1e3-82fd3155dee6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 80005-155-18 | 80005015518 | 100 mL in 1 BOTTLE (80005-155-18) | 100 ml | 2025-01-15 | No | No | Current |